跳至主要内容
临床试验/NCT04806295
NCT04806295招募中不适用

The Leukemia and Lymphoma Society (LLS) National Research Registry

Lymphoma and Leukemia Society1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年7月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
LLS will monitor outcomes of people being treated for blood cancer.

研究概览

简要总结

The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.

详细描述

The LLS National Research Registry is a real-world experiences and outcomes research registry; a collection of patient information and medical data, over time, about people who have a particular disease or condition, or who receive a particular treatment.

The LLS National Research Registry Protocol will:

  1. Answer research questions using data collected from people with blood cancers. Such research involves analyses of subject profile information completed by subjects and medical records data.
  2. Obtain permission from LLS National Research Registry research subjects to have Ciitizen, a third-party engaged by LLS, act as their proxy to retrieve full medical record data including images at no cost to research subjects. Note: Patient can choose to upload their medical records into their account, directly.
  3. Obtain permission from LLS National Research Registry research subjects to share summary data with research partners (like academic researchers, advocacy groups, and pharmaceutical companies) that are advancing treatments for blood cancer. "Summary data" represents the important elements of medical record data, coded for research use, with personal identifiers like name, address, and phone number removed.
  4. Obtain permission from LLS National Research Registry research subjects to be contacted from time to time, for them to provide updated medical information.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • People with blood cancer, before, during, and after blood cancer treatments.

排除标准

  • People unable or unwilling to sign informed consent.

结局指标

主要结局

LLS will monitor outcomes of people being treated for blood cancer.

时间窗: 10 years

. The LLS National Research Registry will collect data on up to 1000 research subjects, over up to 10 years, storing that data, including protected health information (PHI) and images, in secure databases, and share de-identified summary data with research partners (like academic researchers, advocacy groups, and pharmaceutical companies) that are advancing treatments for blood cancer. Participation in The LLS National Research Registry may not give research subjects any immediate benefit. It is hoped the knowledge gained from data collected in The LLS National Research Registry will benefit people with blood cancers in the future using this information for research purposes, directed at blood cancers and associated comorbidities.

次要结局

未报告次要终点

研究者

发起方
Lymphoma and Leukemia Society
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验